Trial Profile
Efficacy and safety of the suppository of Recombinant Streptokinase in the hemorrhoidal acute disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Oct 2020
Price :
$35
*
At a glance
- Drugs Streptokinase (Primary)
- Indications Haemorrhoids
- Focus Therapeutic Use
- Acronyms THERESA-2
- 31 Jul 2013 Status changed from active, no longer recruiting to completed as reported by Cuban Clinical Trial Registry.
- 08 Sep 2011 New trial record